Login
$REGN
$953.36 After hours

Company Executives

Officer Age In this role Joined 2025 pay Source
Leonard S. Schleifer Also a director
President and Chief Executive Officer; co-Chair of the Board
73 Not stated Not stated Not reported
George D. Yancopoulos Also a director
President and Chief Scientific Officer; co-Chair of the Board
66 Not stated Not stated Not reported
Andrew J. Murphy
Executive Vice President, Co-Chief Scientific Officer
68 Since 2026
this year
Not stated $8,477,119
Christopher Fenimore
EVP Finance CFO
Title from the Form 4 dated Nov 2, 2026
55 Not stated Not stated $6,985,364
Joseph J. LaRosa
EVP General Counsel and Secret
Title from the Form 4 dated Nov 2, 2026
67 Not stated Not stated $7,458,970
Marion McCourt
Executive Vice President, Commercial
66 Since 2021
5 years
Not stated Not reported
Jason Pitofsky
Senior Vice President, Controller
49 Since 2026
this year
2011 Not reported
Daniel P. Van Plew
EVP & General Mgr, Industrial
Title from the Form 4 dated Dec 9, 2025
53 Since 2016
10 years
2007 $8,780,263

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
13
serving now
Independent
11 of 11
stated in the proxy; 2 not stated
Average tenure
19.2 years
from year joined
CEO also chairs the board
Yes
Leonard S. Schleifer, M.D., Ph.D. and George D. Yancopoulos, M.D., Ph.D.
Director Age On board Independent Committees Other public boards Pay Source
Leonard S. Schleifer, M.D., Ph.D.
73 1988
38 years
Not stated
Technology Committee
None stated Paid as CEO
George D. Yancopoulos, M.D., Ph.D.
66 2001
25 years
Not stated
Technology Committee
None stated Not stated
Christine A. Poon
73 2010
16 years
Independent None stated Neurocrine Biosciences, Inc., Prudential Financial, Inc. Not stated
Joseph L. Goldstein, M.D.
85 1991
35 years
Independent
Technology Committee
None stated Not stated
David P. Schenkein, M.D.
68 2023
3 years
Independent
Compensation Committee Technology Committee
Denali Therapeutics Inc., Prime Medicine, Inc. Not stated
Craig B. Thompson, M.D.
73 2022
4 years
Independent
Technology Committee
Charles River Laboratories International, Inc. Not stated
Huda Y. Zoghbi, M.D.
71 2016
10 years
Independent
Compensation Committee Technology Committee
None stated Not stated
N. Anthony Coles, M.D.
65 2017
9 years
Independent
Audit Committee Compensation Committee
None stated Not stated
Kathryn Guarini, Ph.D.
54 2023
3 years
Independent
Audit Committee
None stated Not stated
Arthur F. Ryan
83 2003
23 years
Independent
Audit Committee
None stated Not stated
George L. Sing
76 1988
38 years
Independent
Audit Committee · Chair Compensation Committee
None stated Not stated
Bonnie L. Bassler, Ph.D.
63 2016
10 years
Independent
Technology Committee
Royalty Pharma plc Not stated
Michael S. Brown, M.D.
85 1991
35 years
Independent None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 24, 2026
Dr. Schleifer
Amount not stated
2025 and 2026 to date

Company conducted a pre-clinical research project at Dr. Schleifer's request; foundation made or is expected to make payments representing the estimated fully burdened cost of the project

With a foundation established by Dr. Schleifer Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support